Patent Foramen Ovale Occluder

An occluder device designed for the closure of patent ductus arteriosus (PDA) in cardiac patients. It is part of the Occlunix® occluders and delivery systems product line.

Left atrial appendage occluder designed to prevent thromboembolic stroke in patients with atrial fibrillation. This interventional device provides mechanical closure of the left atrial appendage, eliminating the need for long-term anticoagulation therapy. The occluder is delivered via minimally invasive catheter-based approach for cardiac structural intervention.

A septal occluder device designed for the percutaneous closure of ventricular septal defects (VSD) in the heart. It is part of the Occlunix® occluders and delivery systems product line for cardiac intervention.

Braiding machinery for producing medical occluders used in interventional cardiology and closure procedures. Generates precise braided structures for septal defect and vascular closure devices.

A Class III implantable device for patent foramen ovale closure using biodegradable materials that naturally resorb after tissue integration. This system represents China's first degradable PFO closure product approved through expedited regulatory pathway.

Interventional implant for treating structural cardiac defects such as atrial septal defects or patent foramen ovale. Provides percutaneous closure without open surgery.

High-precision components for cardiac septal defect and patent foramen ovale closure devices. Engineered for precise deployment and long-term stability.

Braiding machine dedicated to production of occluder devices used in minimally invasive closure procedures for cardiac defects and vascular anomalies. Provides precise control for complex braided structures.

Nitinol mesh and frame components for atrial septal defect and patent foramen ovale closure devices. Engineered for secure positioning and reliable long-term occlusion.

Percutaneous closure device used to achieve hemostasis at arterial puncture sites following interventional procedures, reducing vascular complications.

Minimally invasive intervention device for structural heart disease treatment including atrial septal defect and left atrial appendage closure applications.